Short-term high-dose treatment in bad-risk ALL and lymphoblastic NHL

Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group.

Leukemia·2005

Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups.

Leukemia·2005

HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.

Gene therapy·2005

Normalized ultraviolet (UV) induction of Langerhans cell depletion and neutrophil infiltrates after artificial UVB hardening of patients with polymorphic light eruption.

The British journal of dermatology·2005

Hematology patterns of migrating European eels and the role of EVEX virus.

Comparative biochemistry and physiology. Toxicology & pharmacology : CBP·2005

FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma.

The Journal of pathology·2005

Age as a core disease modifier: Distinct clinical, molecular and prognostic landscapes of essential thrombocythaemia in adolescents and young adults.

British journal of haematology·2026

Comparison of venetoclax and azacitidine versus a cytarabine-based treatment for patients with acute myeloid leukaemia in first relapse after chemotherapy. A real-world study of the DATAML-IPC-AURAML consortium.

British journal of haematology·2026

Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi.

British journal of haematology·2026

Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.

British journal of haematology·2026

BCMA versus GPRC5D bispecific antibodies in relapsed/refractory multiple myeloma: A systematic review and meta-analysis guiding treatment selection.

British journal of haematology·2026

Development and validation of a machine learning model based on routine laboratory tests for predicting FLT3-ITD mutations in acute myeloid leukaemia.

British journal of haematology·2026

Trastuzumab Deruxtecan-Associated Pneumonitis in Non-Breast Solid Tumors: A Retrospective Cohort Study.

Journal of immunotherapy and precision oncology·2026

Radiation Monotherapy for Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type: A Case Report.

Cureus·2026

A prospective clinical study to understand the factors affecting healing of intestinal primary repair and anastomosis at a tertiary care centre.

Bioinformation·2026

Liver transplantation for pediatric liver tumors: a case report of hepatic angiosarcoma with literature review.

Quantitative imaging in medicine and surgery·2026

Clinical presentation and epidemiological patterns of breast lesions: Experience from a tertiary care hospital.

Bioinformation·2026

Potential utilization of lymphoscintigraphy in patients with kaposiform hemangioendothelioma.

Quantitative imaging in medicine and surgery·2026

Related Experiment Videos

Short-term high-dose treatment in bad-risk ALL and lymphoblastic NHL

Related Concept Videos

HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.

Normalized ultraviolet (UV) induction of Langerhans cell depletion and neutrophil infiltrates after artificial UVB hardening of patients with polymorphic light eruption.

Hematology patterns of migrating European eels and the role of EVEX virus.

FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma.

Age as a core disease modifier: Distinct clinical, molecular and prognostic landscapes of essential thrombocythaemia in adolescents and young adults.

Comparison of venetoclax and azacitidine versus a cytarabine-based treatment for patients with acute myeloid leukaemia in first relapse after chemotherapy. A real-world study of the DATAML-IPC-AURAML consortium.

Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi.

Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.

BCMA versus GPRC5D bispecific antibodies in relapsed/refractory multiple myeloma: A systematic review and meta-analysis guiding treatment selection.

Development and validation of a machine learning model based on routine laboratory tests for predicting FLT3-ITD mutations in acute myeloid leukaemia.

Trastuzumab Deruxtecan-Associated Pneumonitis in Non-Breast Solid Tumors: A Retrospective Cohort Study.

Radiation Monotherapy for Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type: A Case Report.

A prospective clinical study to understand the factors affecting healing of intestinal primary repair and anastomosis at a tertiary care centre.

Liver transplantation for pediatric liver tumors: a case report of hepatic angiosarcoma with literature review.

Clinical presentation and epidemiological patterns of breast lesions: Experience from a tertiary care hospital.

Potential utilization of lymphoscintigraphy in patients with kaposiform hemangioendothelioma.

Related Experiment Videos

Short-term high-dose treatment in bad-risk ALL and lymphoblastic NHL

Related Concept Videos

Related Articles